<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:43:19Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3289644" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3289644</identifier><datestamp>2012-03-02</datestamp><setSpec>plosone</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3289644</article-id>
      <article-id pub-id-type="pmcid">PMC3289644</article-id>
      <article-id pub-id-type="pmc-uid">3289644</article-id>
      <article-id pub-id-type="pmid">22389686</article-id>
      <article-id pub-id-type="pmid">22389686</article-id>
      <article-id pub-id-type="publisher-id">PONE-D-11-22662</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0032187</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Anatomy and Physiology</subject>
            <subj-group>
              <subject>Immune Physiology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Biochemistry</subject>
            <subj-group>
              <subject>Proteins</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Biophysics</subject>
          </subj-group>
          <subj-group>
            <subject>Computational Biology</subject>
            <subj-group>
              <subject>Macromolecular Structure Analysis</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Immunology</subject>
            <subj-group>
              <subject>Immune System</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Anatomy and Physiology</subject>
            <subj-group>
              <subject>Immune Physiology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Clinical Immunology</subject>
            <subj-group>
              <subject>Immune System</subject>
            </subj-group>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Structural Analysis of the C-Terminal Region (Modules 18â20) of Complement Regulator Factor H (FH)</article-title>
        <alt-title alt-title-type="running-head">Crystal Structure of FH18-20</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Morgan</surname>
            <given-names>Hugh P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Mertens</surname>
            <given-names>Haydyn D. T.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Guariento</surname>
            <given-names>Mara</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
          <xref ref-type="author-notes" rid="fn1">
<sup>Â¤a</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schmidt</surname>
            <given-names>Christoph Q.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
          <xref ref-type="author-notes" rid="fn1">
<sup>Â¤a</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Soares</surname>
            <given-names>Dinesh C.</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Svergun</surname>
            <given-names>Dmitri I.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Herbert</surname>
            <given-names>Andrew P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barlow</surname>
            <given-names>Paul N.</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hannan</surname>
            <given-names>Jonathan P.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
          <xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref>
          <xref ref-type="author-notes" rid="fn2">
<sup>Â¤b</sup>
</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
<label>1</label>
<addr-line>Institute of Structural and Molecular Biology, School of Biological Sciences, King's Buildings, University of Edinburgh, Edinburgh, United Kingdom</addr-line>
</aff>
      <aff id="aff2">
<label>2</label>
<addr-line>European Molecular Biology Laboratory, Hamburg Outstation, Hamburg, Germany</addr-line>
</aff>
      <aff id="aff3">
<label>3</label>
<addr-line>Edinburgh Biomolecular NMR Unit, EaStCHEM, School of Chemistry, University of Edinburgh, Edinburgh, United Kingdom</addr-line>
</aff>
      <aff id="aff4">
<label>4</label>
<addr-line>Centre for Molecular Medicine, Institute of Genetics and Molecular Medicine, The University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom</addr-line>
</aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Hofmann</surname>
            <given-names>Andreas</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">Griffith University, Australia</aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email>Jonathan.Hannan@ucdenver.edu</email></corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: HPM HDTM DIS PNB JPH. Performed the experiments: HPM HDTM JPH. Analyzed the data: HPM HDTM MG CQS DCS PNB JPH. Contributed reagents/materials/analysis tools: HDTM MG CQS DCS APH. Wrote the paper: HDTM PNB JPH.</p>
        </fn>
        <fn id="fn1" fn-type="current-aff">
          <label>Â¤a</label>
          <p>Current address: Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America</p>
        </fn>
        <fn id="fn2" fn-type="current-aff">
          <label>Â¤b</label>
          <p>Current address: Division of Rheumatology, Department of Medicine, Barbara Davis Center for Childhood Diabetes, Anshutz Medical Campus, University of Colorado Denver, Aurora, Colorado, United States of America</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>2</month>
        <year>2012</year>
      </pub-date>
      <volume>7</volume>
      <issue>2</issue>
      <elocation-id>e32187</elocation-id>
      <history>
        <date date-type="received">
          <day>11</day>
          <month>11</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>1</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Morgan et al.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Factor H (FH) is a soluble regulator of the human complement system affording protection to host tissues. It selectively inhibits amplification of C3b, the activation-specific fragment of the abundant complement component C3, in fluid phase and on self-surfaces and accelerates the decay of the alternative pathway C3 convertase, C3bBb. We have determined the crystal structure of the three carboxyl-terminal complement control protein (CCP) modules of FH (FH18â20) that bind to C3b, and which additionally recognize polyanionic markers specific to self-surfaces. These CCPs harbour nearly 30 disease-linked missense mutations. We have also deployed small-angle X-ray scattering (SAXS) to investigate FH18â20 flexibility in solution using FH18â20 and FH19â20 constructs. In the crystal lattice FH18â20 adopts a âJâ-shape: A â¼122-degree tilt between the structurally highly similar modules 18 and 19 precedes an extended, linear arrangement of modules 19 and 20 as observed in previously determined structures of these two modules alone. However, under solution conditions FH18â20 adopts multiple conformations mediated by flexibility between CCPs 18 and 19. We also pinpoint the locations of disease-associated missense mutations on the module 18 surface and discuss our data in the context of the C3b:FH interaction.</p>
      </abstract>
      <counts>
        <page-count count="10"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Complement factor H (FH), a 155-kDa soluble glycoprotein abundant in human plasma, is an important regulator of the complement system, the chief molecular component of innate immunity. FH is a member of the regulators of complement activation (RCA) family (reviewed in <xref rid="pone.0032187-Schmidt1" ref-type="bibr">[1]</xref>) that are characterized by possession of repeating compact domains, known as complement control protein modules (CCPs), sushi domains or short consensus repeats <xref rid="pone.0032187-Kirkitadze1" ref-type="bibr">[2]</xref>, <xref rid="pone.0032187-Norman1" ref-type="bibr">[3]</xref>. In FH twenty CCPs are arranged in a tandem manner <xref rid="pone.0032187-Ripoche1" ref-type="bibr">[4]</xref>.</p>
      <p>Human FH binds to, and regulates levels of, the first activation-specific cleavage product of complement component C3, C3b. Without regulation, C3b self-promulgates via formation of the complex, C3bBb, which proteolyses C3, producing more C3b. C3b can attach indiscriminately to surfaces <italic>via</italic> a thioester-containing domain (TED), and is an opsonin. It also triggers a proteolytic cascade terminating in self-assembly of cytolytic pores. FH is a cofactor for proteolysis of C3b to iC3b that no longer participates in the complement cascade but remains opsonic and is a ligand for receptors on B-cells and phagocytes. FH also competes with factor B for binding to C3b, and it accelerates the irreversible decay of C3bBb <xref rid="pone.0032187-Pangburn1" ref-type="bibr">[5]</xref>â<xref rid="pone.0032187-Whaley1" ref-type="bibr">[7]</xref>. Furthermore, FH recognizes polyanionic markers, such as glycosaminoglycans (GAGs) that are common on self-surfaces but rare on pathogen surfaces <xref rid="pone.0032187-Meri1" ref-type="bibr">[8]</xref>â<xref rid="pone.0032187-Pangburn2" ref-type="bibr">[10]</xref>. This dual C3b and polyanion recognition allows FH to regulate complement activation effectively on self-surfaces but not on foreign ones <xref rid="pone.0032187-Pangburn2" ref-type="bibr">[10]</xref>.</p>
      <p>The four FH amino-terminal CCPs (1â4) perform co-factor and C3bBb decay-accelerating activities, while the two carboxyl-terminal CCPs (19â20) also bind C3b but additionally bind to GAGs <xref rid="pone.0032187-Gordon1" ref-type="bibr">[11]</xref>â<xref rid="pone.0032187-Sharma1" ref-type="bibr">[14]</xref>. The crystal structures of a FH1â4:C3b complex <xref rid="pone.0032187-Wu1" ref-type="bibr">[15]</xref>, confirmed separately by fluorescence resonance energy transfer-derived data <xref rid="pone.0032187-Pechtl1" ref-type="bibr">[16]</xref>, and of FH19â20 complexed with C3d (a 35-kDa C3 opsonic proteolytic fragment equivalent to the TED in C3b) have previously been determined <xref rid="pone.0032187-Kajander1" ref-type="bibr">[17]</xref>, <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>. Principal GAG (and sialic acid)-binding regions occupy CCPs 6â8 and CCP 20 <xref rid="pone.0032187-Schmidt2" ref-type="bibr">[13]</xref>, <xref rid="pone.0032187-Kajander1" ref-type="bibr">[17]</xref>, <xref rid="pone.0032187-Blackmore1" ref-type="bibr">[19]</xref>â<xref rid="pone.0032187-Prosser1" ref-type="bibr">[24]</xref>. CCPs 19â20 recognise a composite binding site consisting of surface-tethered C3d (TED) and nearby GAGs, and are thus crucial for ensuring FH acts most effectively at self-surfaces <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>. In current models, the 20 FH CCPs, connected by linkers of three to eight residues, adopt a bent-back conformation with varying degrees of flexibility between modules <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>, <xref rid="pone.0032187-Aslam1" ref-type="bibr">[25]</xref>â<xref rid="pone.0032187-Schmidt3" ref-type="bibr">[29]</xref>. The two FH termini simultaneously engage proximal binding sites on a common surface-tethered C3b molecule; the intervening 14 modules loop out such that CCPs 6â8 approach the surface, reinforcing the GAG-recognition properties of CCP 20 <xref rid="pone.0032187-Kajander1" ref-type="bibr">[17]</xref>, <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>.</p>
      <p>Given its key role in host cell protection it is unsurprising that FH sequence variations associate with diseases including membranoproliferative glomerulonephritis type II, age-related macular degeneration (AMD) and atypical haemolytic uraemic syndrome (aHUS) (reviewed in <xref rid="pone.0032187-deCordoba1" ref-type="bibr">[30]</xref>, and <xref rid="pone.0032187-Boon1" ref-type="bibr">[31]</xref>). Interestingly, the majority of disease-associated missense mutations are clustered in CCPs 18â20 <xref rid="pone.0032187-Boon1" ref-type="bibr">[31]</xref>â<xref rid="pone.0032187-Guigonis1" ref-type="bibr">[36]</xref>.</p>
      <p>In this study we describe the crystal structure of the three carboxyl-terminal CCP modules of human FH (CCPs 18â20) at a resolution of 1.8 Ã together with analysis of this region in solution by small angle X-ray scattering (SAXS). This new structural information extends current knowledge based on the CCPs 19â20 structures and provides a more robust structural context for discussion of disease-linked mutations.</p>
    </sec>
    <sec sec-type="methods" id="s2">
      <title>Methods</title>
      <sec id="s2a">
        <title>Expression and Production of Recombinant FH18â20 &amp; FH19â20</title>
        <p>Recombinant versions of FH18â20 and FH19â20 comprising residues 1046â1231 and residues 1107â1231 (UniProt accession number: P08603), respectively, were expressed and purified as previously described <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>, <xref rid="pone.0032187-Herbert2" ref-type="bibr">[37]</xref>. Recombinant FH18â20 contained an amino-terminal two-residue cloning artefact (Ala-Gly), while FH19â20 contained an amino-terminal four-residue cloning artefact (Glu-Ala-Glu-Phe). The FH18â20 construct which contains a single N-glycosylation consensus sequence (Asn1095-Trp1096-Thr1097) was deglycosylated using endoglycosidase H<sub>f</sub> (New England Biolabs), according to the manufacturer's instructions, prior to use. For crystallization or small angle X-ray scattering (SAXS) studies, FH18â20 and FH19â20 were concentrated by centrifugation using a Vivaspin 20 (Millipore) concentration device (10 KDa molecular weight cut-off) at 4000Ã g, 20Â°C in phosphate-buffered saline (PBS), pH 7.4 (containing 137 mM NaCl, 8.1 mM Na<sub>2</sub>HPO<sub>4</sub>, 2.7 mM KCl, 1.5 mM KH<sub>2</sub>PO<sub>4</sub>).</p>
      </sec>
      <sec id="s2b">
        <title>FH18â20 Crystallization and Data Collection</title>
        <p>Crystals of FH18â20 were grown at 17Â°C by vapor diffusion from hanging drops. Drops contained 1 Âµl of protein solution (16.8 mg/ml) in PBS with an equal volume of well solution (0.1 M sodium malonate, pH 4.0, 12% w/v polyethylene glycol 3350). Crystals grew within forty-eight hours. Crystals were flash frozen in liquid nitrogen after successive soakings in cryoprotectant solutions containing 10% and 25% v/v glycerol. Intensity data were collected (Ï scans were 1Â° over 180Â°) to a resolution of 1.8 Ã (the edge of the detector) on beamline I03 at the Diamond Light Source (Oxfordshire, UK). Data were indexed with Mosflm <xref rid="pone.0032187-Potterton1" ref-type="bibr">[38]</xref>, and subsequently merged and scaled with SCALA <xref rid="pone.0032187-Evans1" ref-type="bibr">[39]</xref>.</p>
      </sec>
      <sec id="s2c">
        <title>FH18â20 Structure Determination</title>
        <p>A previously elucidated structure of FH19â20 (PDB ID: 3OXU/chain F <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>) was used as a search model for molecular replacement using the program PHASER <xref rid="pone.0032187-McCoy1" ref-type="bibr">[40]</xref>. The resulting model underwent ten cycles of restrained refinement using the program REFMAC <xref rid="pone.0032187-Murshudov1" ref-type="bibr">[41]</xref>. The remaining CCP module (FH18) was built using the PHENIX Autobuild Wizard <xref rid="pone.0032187-Terwilliger1" ref-type="bibr">[42]</xref> and the program COOT <xref rid="pone.0032187-Emsley1" ref-type="bibr">[43]</xref>. This model was subjected to further cycles of restrained refinement and, when appropriate, ligands and water molecules were added to the model using COOT. Disordered regions were carefully modeled into <italic>F<sub>o</sub>âF<sub>c</sub></italic> electron density and changes in <italic>R/R</italic>
<sub>free</sub> (%) values were used to assess final model quality.</p>
        <p>The final structure was composed of one FH18â20 molecule comprising 185 residues (Gly1045-Lys1230), 17 of which exhibit alternate conformations, 170 water molecules, four glycerol molecules and a phosphate ion. No clear electron density was observed for the first or last residues in the recombinant FH18â20 sequence (Ala1044 or Arg1231), while the Thr1184âK1188 region within CCP 20 was disordered; this region was modeled using the NMR-derived FH19â20 structure (PDB ID: 2BZM <xref rid="pone.0032187-Herbert2" ref-type="bibr">[37]</xref>). The <italic>R/R</italic>
<sub>free</sub> values converged for twenty cycles of <italic>REFMAC</italic> at 18.2% and 22.6%, respectively. Data-reduction and refinement statistics are summarized in <xref ref-type="table" rid="pone-0032187-t001">Table 1</xref>. Figures were generated using the PyMOL Molecular Graphics System (Version 1.3, SchrÃ¶dinger, LLC).</p>
        <table-wrap id="pone-0032187-t001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0032187.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Crystallographic data collection and refinement statistics.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0032187-t001-1" xlink:href="pone.0032187.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td colspan="2" align="left" rowspan="1">Data collection</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Space group</td>
                  <td align="left" rowspan="1" colspan="1">P22<sub>1</sub>2<sub>1</sub>
</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Cell dimensions</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>a</italic>, <italic>b</italic>, <italic>c</italic> (Ã)</td>
                  <td align="left" rowspan="1" colspan="1">45.97, 68.60, 77.48</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Resolution (Ã)</td>
                  <td align="left" rowspan="1" colspan="1">51.36-1.80</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>R</italic>
<sub>merge</sub> (%)</td>
                  <td align="left" rowspan="1" colspan="1">5.9 (30.9)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>I</italic>/Ï<italic>I</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">13.7 (3.5)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Completeness (%)</td>
                  <td align="left" rowspan="1" colspan="1">99.7 (99.9)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Multiplicity</td>
                  <td align="left" rowspan="1" colspan="1">4.1 (4.1)</td>
                </tr>
              </tbody>
            </table>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td colspan="2" align="left" rowspan="1">Refinement</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">No. reflections</td>
                  <td align="left" rowspan="1" colspan="1">22011</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
<italic>R</italic>
<sub>work</sub>/<italic>R</italic>
<sub>free</sub> (%)</td>
                  <td align="left" rowspan="1" colspan="1">18.2/22.6</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">No. atoms</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Protein</td>
                  <td align="left" rowspan="1" colspan="1">1570</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ligand</td>
                  <td align="left" rowspan="1" colspan="1">28</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Water</td>
                  <td align="left" rowspan="1" colspan="1">170</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Average protein <italic>B</italic>-factor (Ã<sup>2</sup>)</td>
                  <td align="left" rowspan="1" colspan="1">29.5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">R.m.s. deviations</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Bond lengths (Ã)</td>
                  <td align="left" rowspan="1" colspan="1">0.03</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Bond angles (Â°)</td>
                  <td align="left" rowspan="1" colspan="1">2.05</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Ramachandran</td>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">allowed (%)</td>
                  <td align="left" rowspan="1" colspan="1">98.0 (198/202)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">generous (%)</td>
                  <td align="left" rowspan="1" colspan="1">100.0 (202/202)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">disallowed (%)</td>
                  <td align="left" rowspan="1" colspan="1">0.0 (0/202)</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>Values in parentheses are for the highest resolution shell. 5% of reflections were used as a test set for the calculation of R<sub>free</sub>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s2d">
        <title>Validation and Deposition of FH18â20 Structure</title>
        <p>The geometry of the model was assessed using MolProbity <xref rid="pone.0032187-Davis1" ref-type="bibr">[44]</xref>. Atomic coordinates and the experimental structure factors for our 1.8 Ã structure of FH18â20 have been deposited in the Protein Data Bank with the accession code 3SW0 (PDB ID: 3SW0).</p>
      </sec>
      <sec id="s2e">
        <title>Small-Angle X-ray Scattering</title>
        <p>Synchrotron radiation X-ray scattering data were collected on the X33 beam line of the EMBL (DESY, Hamburg, Germany) using a Pilatus one-megapixel array detector (Dectris, Switzerland) and eight frames of 15-second exposure times. Solutions of FH18â20 and FH19â20 were measured at 20Â°C in PBS, pH 7.4, 1 mM DL-Dithiothreitol (DTT) at protein concentrations of 1.9, 3.8 and 7.6 mg/ml (for FH18â20) and 2.4, 4.6 and 7.9 mg/ml (for FH19â20). The sample-to-detector distance was 2.7 m, covering a range of momentum transfer 0.07 nm<sup>â1</sup>&lt;<italic>s</italic>&lt;6.0 nm<sup>â1</sup> (<italic>s</italic>â=â4ÏsinÎ¸/Î», where 2Î¸ is the scattering angle, and Î»â=â0.15 nm is the X-ray wavelength). Addition of reducing agents, such as DTT, serve as free radical scavengers and can significantly reduce radiation damage to biological samples <xref rid="pone.0032187-Maleknia1" ref-type="bibr">[45]</xref>. Comparison of successive 15-second frames revealed no detectable radiation damage in the presence of DTT. However, in the absence of DTT, significant radiation damage occurred following the second frame. Usage of 1 mM DTT in our hands has been shown to be insufficient to reduce disulphide bonds within CCP-containing constructs (data not shown). Data from the detector were normalized to the transmitted beam intensity, averaged and the scattering of buffer solutions subtracted. Difference curves were scaled for solute concentration. All data manipulations were performed using the <italic>PRIMUS</italic> software package 16 <xref rid="pone.0032187-Konarev1" ref-type="bibr">[46]</xref>.</p>
        <p>Fitting of the FH18â20 and FH19â20 (PDB ID: 3OXU <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>) crystal structures to the SAXS data was conducted using the program CRYSOL <xref rid="pone.0032187-Svergun1" ref-type="bibr">[47]</xref>. CRYSOL calculates the partial scattering amplitudes of proteins from their atomic coordinates, taking into account the hydration layer and excluded solvent volume. Low resolution shape envelopes were determined from the solution scattering data using the program DAMMIF <xref rid="pone.0032187-Franke1" ref-type="bibr">[48]</xref> and the most typical model from multiple reconstructions (10) identified using DAMAVER <xref rid="pone.0032187-Volkov1" ref-type="bibr">[49]</xref>. Resulting bead models were converted to meshed envelopes and visualized using PYMOL (Version 1.3, SchrÃ¶dinger, LLC). Superposition of available bead models on three-dimensional structures of FH18â20 or FH19â20, as appropriate, were carried out using the program SUPCOMB13 <xref rid="pone.0032187-Kozin1" ref-type="bibr">[50]</xref>. Rigid body modeling using the program CORAL (Complexes with Random Loops) was also conducted using the FH18â20 crystal structure, constraining either FH modules 18 and 19, or 19 and 20 as fixed, and refining the relative position and orientation of modules 20 or 18, respectively, against the SAXS data <xref rid="pone.0032187-Petoukhov1" ref-type="bibr">[51]</xref>.</p>
        <p>Analysis of inter-domain flexibility in FH18â20 employed the ensemble optimization method (EOM) <xref rid="pone.0032187-Bernado1" ref-type="bibr">[52]</xref>. This uses a genetic algorithm to select, from a pool of randomly generated models, an ensemble of possible conformations whose combined theoretical scattering profiles best fit the experimental data. The CCP modules of FH18â20 were treated as rigid bodies and the linkers between them represented as flexible chains of dummy residues. For the pool, 10,000 models were generated from the input structures. A final ensemble of 20 conformations was selected by genetic algorithm after 50 cycles.</p>
        <p>The discrepancies (Ï) between models/ensembles and the experimental data from CRYSOL, DAMMIF, CORAL and EOM are summarised in <xref ref-type="supplementary-material" rid="pone.0032187.s002">Table S1</xref>. This discrepancy is defined as:<disp-formula><graphic xlink:href="pone.0032187.e001.jpg" mimetype="image" position="float"/><label>(1)</label></disp-formula>where <italic>N</italic> is the number of experimental points, <italic>I<sub>exp</sub>(s<sub>j</sub>)</italic> and <italic>I<sub>calc</sub>(s<sub>j</sub>)</italic> are the experimental and calculated scattering intensities, <italic>c</italic> is a scaling factor and <italic>Ï(s<sub>j</sub>)</italic> is the experimental error at the momentum transfer <italic>s<sub>j</sub></italic>.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <sec id="s3a">
        <title>Crystal Structure of FH18â20</title>
        <p>FH18â20 crystals diffracted to a maximum resolution of 1.8 Ã (see <xref ref-type="table" rid="pone-0032187-t001">Table 1</xref>). FH18â20 data were indexed in the space-group P22<sub>1</sub>2<sub>1</sub>, with one monomer in the asymmetric unit. The three CCP modules of FH18â20 form a âJâ-shaped structure (<xref ref-type="fig" rid="pone-0032187-g001">Figure 1A</xref>). CCPs 19 and 20 adopt an extended rod-like conformation in which CCP 20 is approximately aligned with CCP 19, consistent with previous structural studies carried out using wild-type or mutant forms of FH19â20 <xref rid="pone.0032187-Kajander1" ref-type="bibr">[17]</xref>, <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>, <xref rid="pone.0032187-Morgan2" ref-type="bibr">[22]</xref>, <xref rid="pone.0032187-Herbert2" ref-type="bibr">[37]</xref>, <xref rid="pone.0032187-Bhattacharjee1" ref-type="bibr">[53]</xref>, <xref rid="pone.0032187-Jokiranta1" ref-type="bibr">[54]</xref>; CCPs 19â20 of our FH18â20 structure (PDB ID: 3SW0) may be superimposed (residues 1109â1228, back-bone atoms) with a root-mean-square (rms) of 1.21 Ã on a crystal structure of wild-type FH19â20 (PDB ID: 3OXU/chain F <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>). Both FH18 and FH19 are typical CCP modules with very similar structures (rms, alpha-carbon atoms, â¼1 Ã) in line with their high sequence similarity, while CCP 20 exhibits great structural divergence (rms, alpha-carbon atoms &gt;2 Ã to all but one other CCP module) (<xref ref-type="supplementary-material" rid="pone.0032187.s003">Table S2</xref>) <xref rid="pone.0032187-Soares1" ref-type="bibr">[55]</xref>. While the long axes of CCPs 19 and 20 are approximately aligned, with only a â¼32Â° tilt relative to one another, the long axis of CCP 18 is strongly tilted, by â¼122Â° with respect to the long axis of CCP 19, and by â¼151Â° with respect to CCP 20 (<xref ref-type="supplementary-material" rid="pone.0032187.s004">Table S3</xref>). This distinctive kink in the FH18â20 structure is facilitated by an extensive network of hydrogen bonds (<xref ref-type="fig" rid="pone-0032187-g001">Figure 1</xref>). Atomic distances consistent with hydrogen bond formation are observed between Gln1101 (CCP 18)-Gln1156 (CCP 19); Lys1103 (linker)-Asn1154 (CCP 19); and Lys1103 (linker)-Gln1156 (CCP 19). In addition, a single water molecule (B-factorâ=â25 Ã<sup>2</sup>) forms three hydrogen bonds, one with the amide of Asp1104 (linker) and two with the backbone carbonyl oxygen atoms of Lys1108 (linker) and Gly1155 (CCP 19). Further hydrogen bonding involving residues: Asp1104 (linker)-Ser1105 (linker); Asp1104 (linker)-Gly1107 (linker); Thr1106 (linker)-Lys1108 (linker); and Arg1153 (CCP 19)-Gln1156 (CCP 19) (<xref ref-type="fig" rid="pone-0032187-g001">Figure 1B,C</xref>) also contribute to the kink between CCPs 18 and 19. This network of hydrogen bonds may also stabilize the observed CCP 18âCCP 19 inter-modular orientation under solution conditions; however, we cannot rule out the possibility that the distinctive kinked structure is induced by crystal contacts, or alternatively, by the low-pH conditions employed to crystallize the molecule. Furthermore, the surface area buried between CCPs 18 and 19 is only â¼400 Ã, compared to almost â¼700 Ã for CCPs 19 and 20 (<xref ref-type="supplementary-material" rid="pone.0032187.s005">Table S4</xref>).</p>
        <fig id="pone-0032187-g001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0032187.g001</object-id>
          <label>Figure 1</label>
          <caption>
            <title>Crystal structure of FH18â20 (PDB ID: 3SW0).</title>
            <p>A, A Cartoon representation of the three CCP modules is indicated: CCP 18 (residues 1048â1102), CCP 19 (residues 1109â1163), and CCP 20 (residues 1167â1228). Highlighted on the FH18â20 structure are the C3b-binding (green) and polyanion-binding (blue) regions <xref rid="pone.0032187-Kajander1" ref-type="bibr">[17]</xref>, <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>, <xref rid="pone.0032187-Herbert1" ref-type="bibr">[21]</xref>. Residues contributing to the inter-domain packing between CCPs 18 and 19 are shown. B, Close-up of the kink that occurs between modules 18 and 19. The orientation of the FH18â20 molecule is the same as shown in âAâ. Electron density (2<italic>F</italic>oâ<italic>F</italic>c map shown in grey, and contoured at 1.5Ï) for residues contributing to the inter-modular packing is shown. Dashed lines represent hydrogen-bonds between amino acid residues or between amino acid residues and water molecules. C, as for âBâ except the molecule is rotated about the <italic>y</italic>-axis by 180Â°.</p>
          </caption>
          <graphic xlink:href="pone.0032187.g001"/>
        </fig>
      </sec>
      <sec id="s3b">
        <title>SAXS Analysis of FH18â20 and FH19â20</title>
        <p>To investigate the conformation adopted by these three C-terminal CCP modules in solution, SAXS data were acquired on samples of both FH18â20 and FH19â20 (<xref ref-type="table" rid="pone-0032187-t002">Table 2</xref>). For the double module, FH19â20, the overall parameters suggest that the sample is predominantly monomeric in solution (<xref ref-type="table" rid="pone-0032187-t002">Table 2</xref>). The MW as estimated from the forward scattering intensity of the merged data extrapolated to infinite dilution, <italic>I(0)</italic> is â¼15 kDa, and along with estimates derived from the hydrated particle volumes and <italic>ab initio</italic> bead modelling, is consistent with monomeric FH19â20 in solution (<xref ref-type="fig" rid="pone-0032187-g002">Figure 2A</xref>). Fits of the crystal structure of this FH19â20 construct (PDB ID: 3OXU <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>) to the SAXS data using the program CRYSOL are shown in <xref ref-type="fig" rid="pone-0032187-g002">Figure 2</xref>. The structure of FH19â20 provides an excellent fit (Ïâ=â1.4) to the merged scattering data extrapolated to infinite dilution (<xref ref-type="fig" rid="pone-0032187-g002">Figure 2B</xref>), supporting the extended structures previously solved by both X-ray crystallography and NMR for this fragment <xref rid="pone.0032187-Kajander1" ref-type="bibr">[17]</xref>, <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>, <xref rid="pone.0032187-Morgan2" ref-type="bibr">[22]</xref>, <xref rid="pone.0032187-Herbert2" ref-type="bibr">[37]</xref>, <xref rid="pone.0032187-Bhattacharjee1" ref-type="bibr">[53]</xref>, <xref rid="pone.0032187-Jokiranta1" ref-type="bibr">[54]</xref>. The presence of potential flexibility in the three-residue linker between CCPs 19 and 20 was investigated using an ensemble-optimization analysis conducted using the program EOM. The <italic>R<sub>g</sub></italic> distribution from this analysis is characteristic of an extended structure with a small degree of conformational flexibility relative to the pool of random conformers (<xref ref-type="fig" rid="pone-0032187-g002">Figure 2C</xref>).</p>
        <fig id="pone-0032187-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0032187.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Summary of FH19â20 SAXS data.</title>
            <p>A, Superposition of the SAXS-derived shape envelope of recombinant FH19â20 (shown in yellow) on the crystal structure of FH19â20 (PDB ID: 3OXU <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>). Shape envelopes were determined using the <italic>ab initio</italic> bead-modelling program DAMMIF <xref rid="pone.0032187-Franke1" ref-type="bibr">[48]</xref> and superposition of the FH19â20 envelope on the corresponding crystal structure was carried out utilizing the program, SUPCOMB13 <xref rid="pone.0032187-Kozin1" ref-type="bibr">[50]</xref>. B, Fit of the X-ray crystal structure of FH19â20 (solid black line) to the SAXS data extrapolated to infinite dilution (black open circles). The fit of the selected ensemble of conformations from EOM is also shown (solid red line). C, The <italic>R<sub>g</sub></italic> distribution from the ensemble analysis using EOM (pool in grey, selected ensemble in red).</p>
          </caption>
          <graphic xlink:href="pone.0032187.g002"/>
        </fig>
        <table-wrap id="pone-0032187-t002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0032187.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Overall SAXS parameters.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0032187-t002-2" xlink:href="pone.0032187.t002"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Concn mg/ml)</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>R<sub>g</sub><sup>Guinier</sup></italic> (nm)</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>R<sub>g</sub><sup>GNOM</sup></italic> (nm)</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>D<sub>max</sub></italic> (nm)</td>
                  <td align="left" rowspan="1" colspan="1">
<italic>I(0)</italic>
</td>
                  <td align="left" rowspan="1" colspan="1">MW<italic><sup>SAXS</sup></italic> (kDa)</td>
                  <td align="left" rowspan="1" colspan="1">Vol<italic><sup>SAXS</sup></italic>, nm<sup>3</sup>
</td>
                  <td align="left" rowspan="1" colspan="1">Vol<italic><sup>DAM</sup></italic>, nm<sup>3</sup>
</td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">FH19â20 (14.9 kDa)</td>
                  <td align="left" rowspan="1" colspan="1">2.4</td>
                  <td align="left" rowspan="1" colspan="1">2.3Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">2.3Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">8.0Â±0.5</td>
                  <td align="left" rowspan="1" colspan="1">17.4</td>
                  <td align="left" rowspan="1" colspan="1">14Â±5</td>
                  <td align="left" rowspan="1" colspan="1">17</td>
                  <td align="left" rowspan="1" colspan="1">23Â±5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">4.6</td>
                  <td align="left" rowspan="1" colspan="1">2.4Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">2.4Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">8.4Â±0.5</td>
                  <td align="left" rowspan="1" colspan="1">19.2</td>
                  <td align="left" rowspan="1" colspan="1">16Â±5</td>
                  <td align="left" rowspan="1" colspan="1">20</td>
                  <td align="left" rowspan="1" colspan="1">26Â±5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">7.9</td>
                  <td align="left" rowspan="1" colspan="1">2.6Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">2.6Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">9.0Â±0.5</td>
                  <td align="left" rowspan="1" colspan="1">21.2</td>
                  <td align="left" rowspan="1" colspan="1">21Â±5</td>
                  <td align="left" rowspan="1" colspan="1">23</td>
                  <td align="left" rowspan="1" colspan="1">32Â±5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">mer</td>
                  <td align="left" rowspan="1" colspan="1">2.2Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">2.2Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">7.4Â±0.5</td>
                  <td align="left" rowspan="1" colspan="1">18.2</td>
                  <td align="left" rowspan="1" colspan="1">15Â±5</td>
                  <td align="left" rowspan="1" colspan="1">16Â±5</td>
                  <td align="left" rowspan="1" colspan="1">22Â±5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">FH18â20 (21.4 kDa)</td>
                  <td align="left" rowspan="1" colspan="1">1.9</td>
                  <td align="left" rowspan="1" colspan="1">3.0Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">3.2Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">10.6Â±0.5</td>
                  <td align="left" rowspan="1" colspan="1">21.7</td>
                  <td align="left" rowspan="1" colspan="1">18Â±5</td>
                  <td align="left" rowspan="1" colspan="1">21Â±5</td>
                  <td align="left" rowspan="1" colspan="1">29Â±5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">3.8</td>
                  <td align="left" rowspan="1" colspan="1">3.1Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">3.3Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">10.9Â±0.5</td>
                  <td align="left" rowspan="1" colspan="1">22.7</td>
                  <td align="left" rowspan="1" colspan="1">18Â±5</td>
                  <td align="left" rowspan="1" colspan="1">23Â±5</td>
                  <td align="left" rowspan="1" colspan="1">32Â±5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">7.6</td>
                  <td align="left" rowspan="1" colspan="1">3.4Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">3.5Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">11.5Â±0.5</td>
                  <td align="left" rowspan="1" colspan="1">26.6</td>
                  <td align="left" rowspan="1" colspan="1">22Â±5</td>
                  <td align="left" rowspan="1" colspan="1">29Â±5</td>
                  <td align="left" rowspan="1" colspan="1">39Â±5</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">mer</td>
                  <td align="left" rowspan="1" colspan="1">2.9Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">3.2Â±0.1</td>
                  <td align="left" rowspan="1" colspan="1">10.2Â±0.5</td>
                  <td align="left" rowspan="1" colspan="1">21.9</td>
                  <td align="left" rowspan="1" colspan="1">22Â±5</td>
                  <td align="left" rowspan="1" colspan="1">30Â±5</td>
                  <td align="left" rowspan="1" colspan="1">32Â±5</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt102">
              <label/>
              <p>
<italic>R<sub>g</sub><sup>Guinier</sup></italic> and <italic>R<sub>g</sub><sup>GNOM</sup></italic> are the experimentally determined radius of gyration as calculated by Guinier analysis <xref rid="pone.0032187-Guinier1" ref-type="bibr">[62]</xref> and by indirect Fourier transform using the program GNOM, respectively <xref rid="pone.0032187-Svergun2" ref-type="bibr">[63]</xref>; <italic>D<sub>max</sub></italic> is the maximum particle dimension; <italic>I(0)</italic> is the forward scattering intensity; <italic>MW<sup>(SAXS)</sup></italic> is the molecular weight determined by SAXS; Vol<italic><sup>SAXS</sup></italic> is the hydrated particle volume of solutes determined from the SAXS patterns; and Vol<italic><sup>DAM</sup></italic> is the excluded volume of solutes determined using the <italic>ab initio</italic> modeling program DAMMIF <xref rid="pone.0032187-Franke1" ref-type="bibr">[48]</xref>. Data merged and extrapolated to infinite dilution are referred to in the table as âmerâ.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>For FH18â20, the MW estimate of â¼22 kDa from the merged data extrapolated to infinite dilution agreed with that expected for a monomeric form of this three-module protein. Volume estimates were also consistent with a monomeric state, with volumes of 30 and 32 nm<sup>3</sup> measured for the <italic>Vol<sup>SAXS</sup></italic> and <italic>Vol<sup>DAM</sup></italic> values, respectively (corresponding to estimated MW's of 19Â±5 kDa and 16Â±5 kDa). Interestingly, though, the experimentally derived scattering curves did not fit well to data back-calculated from the âJâ-shaped crystal structure (discrepancy Ïâ=â2.4) (<xref ref-type="fig" rid="pone-0032187-g003">Figure 3</xref>); nor did <italic>ab initio</italic> low-resolution shape envelopes generated using the program DAMMIF demonstrate the same acute angle between CCPs 18 and 19 (<xref ref-type="fig" rid="pone-0032187-g003">Figure 3A</xref>) <xref rid="pone.0032187-Franke1" ref-type="bibr">[48]</xref>. Furthermore, SAXS-based rigid body models of FH18â20 generated using the program CORAL, in which the position and orientation of CCP 18 was refined against the SAXS data, resulted in an average solution conformation which was more extended than the crystal structure (<xref ref-type="fig" rid="pone-0032187-g003">Figure 3A</xref>) and which better fit the scattering data (Ïâ=â1.4) (<xref ref-type="supplementary-material" rid="pone.0032187.s001">Figure S1</xref>). By contrast, refinement of the position and orientation of CCP 20 yielded no improvement in the fit to the SAXS data compared to that of the crystal structure (Ïâ=â2.1) (<xref ref-type="supplementary-material" rid="pone.0032187.s001">Figure S1</xref>). Overall, these SAXS results suggest FH18â20 has a more extended conformation in solution than that observed in the crystal lattice. The most straightforward explanation is that under the conditions used to collect the SAXS experiments, FH18â20 is more flexible than might be inferred from its crystal structure.</p>
        <fig id="pone-0032187-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0032187.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>FH18â20 SAXS analysis.</title>
            <p>A, Superposition of the SAXS-derived shape envelope of recombinant FH18â20 (yellow) on the crystal structure of FH18â20 (indicated in cyan), and also on a CORAL-derived rigid body model of FH18â20 (shown in red) where the orientation of CCPs 19â20 are fixed, and the position of CCP 18 refined against the SAXS data. Flexible linker residues (alpha-carbon atoms) are shown as red spheres. B, Fit of the FH18â20 crystal structure (black line) to the SAXS data using the program CRYSOL, and fit of the selected ensemble of FH18â20 models from the EOM analysis (red line) to the SAXS data. C, <italic>R<sub>g</sub></italic> distribution from the EOM analysis of FH18â20 with both FH18â19 and FH19â20 linker regions defined as flexible (pool in grey, selected ensemble in red). D, Fits of the selected ensembles from the EOM analysis of FH18â20 to the SAXS data using flexible FH18â19 (blue line) or FH19â20 (green line) linker regions. E, <italic>R<sub>g</sub></italic> distribution from the EOM analysis for FH18â20 with the FH18â19 linker region defined as flexible (pool in grey, selected ensemble in blue).</p>
          </caption>
          <graphic xlink:href="pone.0032187.g003"/>
        </fig>
        <p>To investigate potential flexibility of the linker regions within CCPs 18â19 and CCPs 19â20, an analysis was carried out with EOM <xref rid="pone.0032187-Bernado1" ref-type="bibr">[52]</xref>. When all inter-module linkers were defined as flexible the genetic algorithm selected an ensemble of conformations providing a superior fit (Ïâ=â1.2) to the SAXS data, compared to that of the crystal structure (<xref ref-type="fig" rid="pone-0032187-g003">Figure 3B</xref>). The <italic>R<sub>g</sub></italic> distribution of the selected ensemble from this analysis is shifted toward extended structures while the width of the distribution is smaller than that of the pool (<xref ref-type="fig" rid="pone-0032187-g003">Figure 3C</xref>), suggesting partial flexibility. To investigate the location of potential flexibility and reduce the number of degrees of freedom of the EOM analysis, two additional runs were conducted. In these, the linker between CCPs 18 and 19 or between 19 and 20 was fixed as in the crystal structure, allowing either CCP 20 or CCP 18, respectively, (<italic>via</italic> the remaining non-fixed linker) to sample conformational space. The SAXS data were fit well by an ensemble in which the 19â20 linker was fixed (Ïâ=â1.3) (<xref ref-type="fig" rid="pone-0032187-g003">Figure 3D</xref>), but were fit poorly by the ensemble in which the 18â19 linker was fixed (Ïâ=â2.4). These data, which are entirely consistent with the experiments performed on FH19â20, suggest that the six residue 18â19 linker, but not the three residue 19â20 linker, is significantly flexible. The <italic>R<sub>g</sub></italic> distribution of the selected ensemble in which the 19â20 linker was fixed coincides well with that of the respective pool, being both broad (and thus considerably flexible) and skewed toward extended structures (<xref ref-type="fig" rid="pone-0032187-g003">Figure 3E</xref>).</p>
        <p>In summary, these data are consistent with a solution of, on average, more extended FH18â20 conformations (compared to the crystal structure) with a rigid 19â20 linker and a highly flexible 18â19 linker. It is possible therefore, that the kinked crystal-derived FH18â20 structure in which CCP 18 folds back towards CCP 19 reflects a snapshot of one of several conformations available to these three modules (<xref ref-type="fig" rid="pone-0032187-g004">Figure 4</xref>).</p>
        <fig id="pone-0032187-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0032187.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>The crystal structure of FH18â20 modeled onto the C3b:FH1â4 complex.</title>
            <p>A, Superposition of FH18â20 structure (PDB ID: 3SW0) on the previously determined wild-type FH19â20:C3d complex (PDB ID: 3OXU <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>) and the FH1â4:C3b complex (PDB ID: 2WII <xref rid="pone.0032187-Wu1" ref-type="bibr">[15]</xref>). Surface representations are shown of FH1â4 (slate) and FH18â20 (cyan). In the cartoon representation of C3b, constituent domains are color-coded with the TED indicated in green. FH19â20 and C3d were employed for alignment purposes only, and are not shown. Also indicated is Gln1013, the site of covalent linkage of C3b to target surfaces. B, As for (A) except the model of the FH1â4:C3b:FH18â20 complex has been rotated about the <italic>y</italic>-axis by 35Â° demonstrating the path of CCP 18 with respect to the FH1â4:C3b complex. C, Schematic of a FH1â4:C3b:FH18â20 complex demonstrating the inferred flexibility, in solution, of the linker connecting CCPs 18 and 19.</p>
          </caption>
          <graphic xlink:href="pone.0032187.g004"/>
        </fig>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>We have extended the structural information available for the key soluble human complement regulator, FH. We elucidated the crystal structure of FH18â20, and have complemented this with the acquisition of solution SAXS data for FH19â20 and FH18â20. These C-terminal CCPs encompass the key self <italic>versus</italic> non-self discriminating region of this protein <xref rid="pone.0032187-Pangburn2" ref-type="bibr">[10]</xref>. While several high-resolution structures of the C3b/GAG-contacting CCPs 19 and 20 were already available, CCP 18 is also of interest since it too is a site of disease-associated mutations (<xref ref-type="fig" rid="pone-0032187-g005">Figure 5</xref>) <xref rid="pone.0032187-Boon1" ref-type="bibr">[31]</xref>, <xref rid="pone.0032187-Saunders1" ref-type="bibr">[35]</xref>, <xref rid="pone.0032187-Guigonis1" ref-type="bibr">[36]</xref>. Moreover, the inter-modular angles between CCPs 18 and 19 are important because they determine the path of the carboxyl-terminal region of the FH molecule as it exits the C3b:FH complex before looping back to re-engage with the same C3b molecule via its amino-terminal CCPs <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>.</p>
      <fig id="pone-0032187-g005" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0032187.g005</object-id>
        <label>Figure 5</label>
        <caption>
          <title>Location of disease-associated missense mutations within CCP 18.</title>
          <p>A, Shown are the alpha-carbons (red spheres) of residues for which missense mutations associated with aHUS or basal laminar drusen have been reported. Residue numbers are: 1050 (basal laminar drusen variant N1050Y) <xref rid="pone.0032187-Boon1" ref-type="bibr">[31]</xref>; 1060 (aHUS-associated variant V1060A) <xref rid="pone.0032187-Guigonis1" ref-type="bibr">[36]</xref>; 1076 (aHUS-associated variant Q1076E) <xref rid="pone.0032187-Perkins1" ref-type="bibr">[32]</xref>, <xref rid="pone.0032187-Richards1" ref-type="bibr">[34]</xref>; and 1078 (basal laminar drusen-associated variant R1078S) <xref rid="pone.0032187-Boon1" ref-type="bibr">[31]</xref>. Also indicated in magenta is the alpha-carbon of residue 1095, the Asn of the sole N-glycosylation consensus sequence located within FH18â20. B, Electrostatic surface representation of FH18â20. Positively and negatively charged areas are indicated in blue and red, respectively. Also shown as a red mesh is a negative isosurface map contoured at â2 kT/e. This figure was generated using the APBS plug-in for PyMOL <xref rid="pone.0032187-Baker1" ref-type="bibr">[64]</xref>.</p>
        </caption>
        <graphic xlink:href="pone.0032187.g005"/>
      </fig>
      <p>FH18â20, in the crystal lattice, adopts a distinctive âJâ-shaped conformation. The short (three-residue) linker between CCPs 19 and 20 (<italic>i.e.</italic> between the last cysteine of CCP 19 and the first of CCP 20) along with numerous inter-modular contacts imposes an approximately linear rod-like structure on this (GAG/C3b-binding) part of the molecule; the longer (six-residue) 18â19 linker permits a sharp kink to form in the molecule, also stabilized by inter-modular and module-to-linker interactions, but with a smaller inter-modular interface than observed between modules 19 and 20. Interestingly, a previously published SAXS-based model of FH 15â19 also contained a kink between CCPs 18 and 19 <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>. On the other hand our SAXS-derived analysis of FH18â20 and FH19â20 in solution revealed the presence of conformational mobility at the 18â19 inter-modular junction, but little flexibility between CCPs 19 and 20. These data are consistent with the low buried surface area which is observed between CCPs 18 and 19 (<xref ref-type="supplementary-material" rid="pone.0032187.s004">Table S3</xref>). Varying levels of inter-modular flexibility have been noted previously in FH and other RCAs <xref rid="pone.0032187-Schmidt2" ref-type="bibr">[13]</xref>, <xref rid="pone.0032187-Kirkitadze2" ref-type="bibr">[56]</xref>â<xref rid="pone.0032187-Soares2" ref-type="bibr">[58]</xref>.</p>
      <p>Taking these data together, it appears that modules 19 and 20 are rigidly aligned such that their rod-like conformation is independent of the addition of CCP 18 or the presence of ligands. Modules 18 and 19, on the other hand, can adopt a bent-back conformation, supported by numerous non-covalent interactions, that would bring residues on the surface of module 18 in close proximity to C3b within a FH:C3b complex rather than projecting module 18 (and the preceding modules of FH) clear of the complex (<xref ref-type="fig" rid="pone-0032187-g004">Figure 4</xref>); but this junction is much less rigid than that between modules 19 and 20. Occupation of a solitary N-glycan site on Asn1095 within CCP 18 (<xref ref-type="fig" rid="pone-0032187-g005">Figure 5</xref>) would not preclude this conformational flexibility due to its remoteness from the CCP 18âCCP 19 linker.</p>
      <p>The carboxyl-terminal region of FH is a hotspot for disease-associated mutations which have been linked to increased risk for the development of aHUS, early onset drusen (basal laminal drusen) and age-related macular degeneration (AMD) <xref rid="pone.0032187-Boon1" ref-type="bibr">[31]</xref>â<xref rid="pone.0032187-Guigonis1" ref-type="bibr">[36]</xref>. To date, at least twenty-eight such missense mutations have been documented in FH18â20, four of which occur in CCP 18: N1050Y <xref rid="pone.0032187-Boon1" ref-type="bibr">[31]</xref>; V1060A <xref rid="pone.0032187-Guigonis1" ref-type="bibr">[36]</xref>; Q1076E <xref rid="pone.0032187-Perkins1" ref-type="bibr">[32]</xref>, <xref rid="pone.0032187-Richards1" ref-type="bibr">[34]</xref>; and R1078S <xref rid="pone.0032187-Boon1" ref-type="bibr">[31]</xref>. All of these substitutions are located on the surface of CCP 18 (<xref ref-type="fig" rid="pone-0032187-g005">Figure 5A</xref>) and none is likely to result in significant structural perturbations; two of them (Q1076E and R1078S), however, alter the electrostatic potential of CCP 18 and are, additionally, in close proximity to an electronegative patch on this module (<xref ref-type="fig" rid="pone-0032187-g005">Figure 5B</xref>). While direct binding to C3b occurs mainly through CCP 19 and the CCP 19â20 inter-modular junction, residues exposed on CCP 18 could nonetheless play a role in the encounter between the C terminus of FH and C3b and therefore modulate the ability of FH to control C3b amplification on host surfaces. In previous work reversal-of-charge mutations in CCPs 19 and 20 were found to influence affinity of FH19â20 for C3d/C3b even when they did not lie directly in the interface between these two molecules as visualized in the crystal structure of the FH19â20:C3d complex <xref rid="pone.0032187-Kajander1" ref-type="bibr">[17]</xref>, <xref rid="pone.0032187-Morgan1" ref-type="bibr">[18]</xref>, <xref rid="pone.0032187-Ferreira1" ref-type="bibr">[59]</xref>, <xref rid="pone.0032187-Lehtinen1" ref-type="bibr">[60]</xref>. Such observations were attributed to electrostatic steering. It has also been suggested that some disease-associated mutations in FH19â20 modulate self-association <xref rid="pone.0032187-Jokiranta1" ref-type="bibr">[54]</xref>. The wild-type FH18â20 protein is monomeric under the conditions used for SAXS. Mutagenesis combined with binding and biophysical studies would be needed to explore the hypothesis that residues in CCP 18 exert electrostatic steering effects, or that mutations in CCP 18 can influence self-association. Alternatively, interactions with other less well established FH ligands might be directly affected by mutations in CCP 18; the inflammatory biomarker, C-reactive protein, for example, has been reported to bind to a FH16â20 construct <xref rid="pone.0032187-Okemefuna2" ref-type="bibr">[61]</xref>.</p>
    </sec>
    <sec sec-type="supplementary-material" id="s5">
      <title>Supporting Information</title>
      <supplementary-material content-type="local-data" id="pone.0032187.s001">
        <label>Figure S1</label>
        <caption>
          <p>
<bold>Fit of FH18â20 rigid body models refined against the SAXS data using the program CORAL.</bold> Fits are shown for rigid body models refining only CCP 18 (CCPs 19â20 fixed) or CCP 20 (CCPs 18â19 fixed), as solid blue and dashed red lines, respectively.</p>
          <p>(PPT)</p>
        </caption>
        <media xlink:href="pone.0032187.s001.ppt">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0032187.s002">
        <label>Table S1</label>
        <caption>
          <p>
<bold>Comparison of the discrepancies (Ï) for the DAMMIF, CORAL and EOM SAXS-derived analyses.</bold>
</p>
          <p>(DOC)</p>
        </caption>
        <media xlink:href="pone.0032187.s002.doc">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0032187.s003">
        <label>Table S2</label>
        <caption>
          <p>
<bold>Pair-wise CCP module structural comparisons of FH18, FH19 and FH20.</bold> Comparison of CCP module structures of CCP 18, CCP 19 and CCP 20 versus all other individual CCPs of known structure within the complement system based upon alpha-carbon RMSD values using the structural alignment program Combinatorial Extension <xref rid="pone.0032187-Morgan2" ref-type="bibr">[22]</xref>. For each CCP, inclusive module boundaries were one residue before Cys-I and the third residue after Cys-IV. In cases where structures have been solved by both NMR and X-ray diffraction, the higher resolution X-ray structure was used for comparison. Where both liganded and unliganded structures were available, the highest resolution unliganded X-ray or NMR structure was used. A few residues were missing in the crystal structure of C1r CCP 2, and hence in this case, the structure with the most determined residues was employed for both modules. Colour key used in table: Blue: 0â1.99 Ã; Green: 2.00â2.99 Ã; Red: 3.00â3.99 Ã; Brown: Alignment lengths &lt;40 amino acids. Abbreviations used in Table: C4BPÎ±â=âC4b-binding protein Î±-chain; CRâ=âcomplement receptor; CRRYâ=ârat Complement receptor 1-related protein Y; DAFâ=âdecay-accelerating factor; FBâ=âfactor B; FHâ=âfactor H; MASP1/2â=âmannan-binding lectin-associated serine proteases 1/2; MCPâ=âmembrane cofactor protein; VCPâ=âVaccinia virus complement control protein. Some residues were not present (solved) in the electron density map for the C1r CCP 2 module crystal structure, and this explains the short structural alignment length (shown in brown).</p>
          <p>(DOC)</p>
        </caption>
        <media xlink:href="pone.0032187.s003.doc">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0032187.s004">
        <label>Table S3</label>
        <caption>
          <p>
<bold>Intermodular angles for CCPs 18â20.</bold> Tilt, twist and skew angles in degrees were determined as previously described <xref rid="pone.0032187-Schmidt1" ref-type="bibr">[1]</xref>, <xref rid="pone.0032187-Kirkitadze1" ref-type="bibr">[2]</xref> using (for a reference <italic>x</italic>-axis) a vector between the principal axis of the inertia tensor (the <italic>z</italic>-axis) and the alpha-carbons of the conserved Trp1096 (CCP 18), Trp1157 (CCP 19) or Leu1223 (CCP 20), respectively, and with module boundaries defined as Cys-I i.e., Cys1048 (CCP 18), Cys1109 (CCP 19), or Cys1167 (CCP 20) and Cys-IV i.e., Cys1102 (CCP 18), Cys1163 (CCP 19), or Cys1228 (CCP 20), respectively.</p>
          <p>(DOC)</p>
        </caption>
        <media xlink:href="pone.0032187.s004.doc">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
      <supplementary-material content-type="local-data" id="pone.0032187.s005">
        <label>Table S4</label>
        <caption>
          <p>
<bold>Accessible surface area and interface buried surface area calculation.</bold> The web server VADAR version 1.8 <xref rid="pone.0032187-Schmidt1" ref-type="bibr">[1]</xref> was used and the surface area (SA) that was buried was calculated as: (SA Module 1+SA Module 2) - SA Bi-module. All units are in Ã<sup>2</sup>. The linker length was defined as the number of residues between the C-terminal Cys of the preceding CCP module and the N-terminal Cys of the following CCP module. For CCP 18 (in CCP 18âCCP 19), boundaries were considered from one residue before the first Cys till three residues after the last Cys and for CCP 19 (in CCP 18âCCP 19 and CCP 19âCCP 20), boundaries were considered from three residues before the first Cys till one residue after the last Cys (and one residue before the first Cys till one residue after last Cys in CCP 19âCCP 20, and two residues before first Cys till one residue after last Cys in CCP 20). For bi-modules, boundaries were considered from one residue before the first Cys of Module 1 to one residue after the last Cys of Module 2.</p>
          <p>(DOC)</p>
        </caption>
        <media xlink:href="pone.0032187.s005.doc">
          <caption>
            <p>Click here for additional data file.</p>
          </caption>
        </media>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>Use of the Protein Production and Biophysical Characterization Facilities at the University of Edinburgh was supported by The Wellcome Trust, the Scottish University Life Sciences Alliance and the BBSRC.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
      </fn>
      <fn fn-type="financial-disclosure">
        <p><bold>Funding: </bold>This work was supported by start-up funding from the School of Biological Sciences at the University of Edinburgh to JPH, by Wellcome Trust grant 073131 to PNB, and by Wellcome Trust grant 088179 to DCS. HDTM was supported by a fellowship from the EMBL Interdisciplinary Postdocs programme (EIPOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="pone.0032187-Schmidt1">
        <label>1</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>CQ</given-names></name><name><surname>Herbert</surname><given-names>AP</given-names></name><name><surname>Hocking</surname><given-names>HG</given-names></name><name><surname>Uhrin</surname><given-names>D</given-names></name><name><surname>Barlow</surname><given-names>PN</given-names></name></person-group>
<year>2008</year>
<article-title>Translational mini-review series on complement factor H: structural and functional correlations for factor H.</article-title>
<source>Clin Exp Immunol</source>
<volume>151</volume>
<fpage>14</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">18081691</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Kirkitadze1">
        <label>2</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirkitadze</surname><given-names>MD</given-names></name><name><surname>Barlow</surname><given-names>PN</given-names></name></person-group>
<year>2001</year>
<article-title>Structure and flexibility of the multiple domain proteins that regulate complement activation.</article-title>
<source>Immunol Rev</source>
<volume>180</volume>
<fpage>146</fpage>
<lpage>161</lpage>
<pub-id pub-id-type="pmid">11414356</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Norman1">
        <label>3</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Norman</surname><given-names>DG</given-names></name><name><surname>Barlow</surname><given-names>PN</given-names></name><name><surname>Baron</surname><given-names>M</given-names></name><name><surname>Day</surname><given-names>AJ</given-names></name><name><surname>Sim</surname><given-names>RB</given-names></name><etal/></person-group>
<year>1991</year>
<article-title>Three-dimensional structure of a complement control protein module in solution.</article-title>
<source>J Mol Biol</source>
<volume>219</volume>
<fpage>717</fpage>
<lpage>725</lpage>
<pub-id pub-id-type="pmid">1829116</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Ripoche1">
        <label>4</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ripoche</surname><given-names>J</given-names></name><name><surname>Day</surname><given-names>AJ</given-names></name><name><surname>Harris</surname><given-names>TJR</given-names></name><name><surname>Sim</surname><given-names>RB</given-names></name></person-group>
<year>1988</year>
<article-title>The complete amino acid sequence of human complement factor H.</article-title>
<source>Biochem J</source>
<volume>249</volume>
<fpage>563</fpage>
<lpage>602</lpage>
</element-citation>
      </ref>
      <ref id="pone.0032187-Pangburn1">
        <label>5</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pangburn</surname><given-names>MK</given-names></name><name><surname>Schreiber</surname><given-names>RD</given-names></name><name><surname>Muller-Eberhard</surname><given-names>HJ</given-names></name></person-group>
<year>1977</year>
<article-title>Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.</article-title>
<source>J Exp Med</source>
<volume>146</volume>
<fpage>257</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="pmid">301546</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Weiler1">
        <label>6</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weiler</surname><given-names>JM</given-names></name><name><surname>Daha</surname><given-names>MR</given-names></name><name><surname>Austen</surname><given-names>KF</given-names></name><name><surname>Fearon</surname><given-names>DT</given-names></name></person-group>
<year>1976</year>
<article-title>Control of the amplification convertase of complement by the plasma protein beta1H.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>73</volume>
<fpage>3268</fpage>
<lpage>3272</lpage>
<pub-id pub-id-type="pmid">1067618</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Whaley1">
        <label>7</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Whaley</surname><given-names>K</given-names></name><name><surname>Ruddy</surname><given-names>S</given-names></name></person-group>
<year>1976</year>
<article-title>Modulation of the alternative complement pathways by beta 1 H globulin.</article-title>
<source>J Exp Med</source>
<volume>144</volume>
<fpage>1147</fpage>
<lpage>1163</lpage>
<pub-id pub-id-type="pmid">62817</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Meri1">
        <label>8</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meri</surname><given-names>S</given-names></name><name><surname>Pangburn</surname><given-names>MK</given-names></name></person-group>
<year>1990</year>
<article-title>Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>87</volume>
<fpage>3982</fpage>
<lpage>3986</lpage>
<pub-id pub-id-type="pmid">1692629</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Meri2">
        <label>9</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Meri</surname><given-names>S</given-names></name><name><surname>Pangburn</surname><given-names>MK</given-names></name></person-group>
<year>1994</year>
<article-title>Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H.</article-title>
<source>Biochem Biophys Res Commun</source>
<volume>198</volume>
<fpage>52</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="pmid">8292049</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Pangburn2">
        <label>10</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pangburn</surname><given-names>MK</given-names></name></person-group>
<year>2000</year>
<article-title>Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement.</article-title>
<source>Immunopharmacology</source>
<volume>49</volume>
<fpage>149</fpage>
<lpage>157</lpage>
<pub-id pub-id-type="pmid">10904114</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Gordon1">
        <label>11</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gordon</surname><given-names>DL</given-names></name><name><surname>Kaufman</surname><given-names>RM</given-names></name><name><surname>Blackmore</surname><given-names>TK</given-names></name><name><surname>Kwong</surname><given-names>J</given-names></name><name><surname>Lublin</surname><given-names>DM</given-names></name></person-group>
<year>1995</year>
<article-title>Identification of complement regulatory domains in human factor H.</article-title>
<source>J Immunol</source>
<volume>155</volume>
<fpage>348</fpage>
<lpage>356</lpage>
<pub-id pub-id-type="pmid">7541419</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Pangburn3">
        <label>12</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pangburn</surname><given-names>MK</given-names></name></person-group>
<year>2002</year>
<article-title>Cutting edge: localization of the host recognition functions of complement factor H at the carboxyl-terminal: implications for hemolytic uremic syndrome.</article-title>
<source>J Immunol</source>
<volume>169</volume>
<fpage>4702</fpage>
<lpage>4706</lpage>
<pub-id pub-id-type="pmid">12391176</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Schmidt2">
        <label>13</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>CQ</given-names></name><name><surname>Herbert</surname><given-names>AP</given-names></name><name><surname>Kavanagh</surname><given-names>D</given-names></name><name><surname>Gandy</surname><given-names>C</given-names></name><name><surname>Fenton</surname><given-names>CJ</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>A new map of glycosaminoglycan and C3b binding sites on factor H.</article-title>
<source>J Immunol</source>
<volume>181</volume>
<fpage>2610</fpage>
<lpage>2619</lpage>
<pub-id pub-id-type="pmid">18684951</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Sharma1">
        <label>14</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharma</surname><given-names>AK</given-names></name><name><surname>Pangburn</surname><given-names>MK</given-names></name></person-group>
<year>1996</year>
<article-title>Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>93</volume>
<fpage>10996</fpage>
<lpage>11001</lpage>
<pub-id pub-id-type="pmid">8855297</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Wu1">
        <label>15</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>YQ</given-names></name><name><surname>Ricklin</surname><given-names>D</given-names></name><name><surname>Janssen</surname><given-names>BJ</given-names></name><name><surname>Lambris</surname><given-names>JD</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>Structure of complement fragment C3b-factor H and implications for host protection by complement regulators.</article-title>
<source>Nat Immunol</source>
<volume>10</volume>
<fpage>728</fpage>
<lpage>733</lpage>
<pub-id pub-id-type="pmid">19503104</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Pechtl1">
        <label>16</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pechtl</surname><given-names>IC</given-names></name><name><surname>Neely</surname><given-names>RK</given-names></name><name><surname>Dryden</surname><given-names>DTF</given-names></name><name><surname>Jones</surname><given-names>AC</given-names></name><name><surname>Barlow</surname><given-names>PN</given-names></name></person-group>
<year>2011</year>
<article-title>Use of time-resolved FRET to validate crystal structure of complement regulatory complex between C3b and factor H (N terminus).</article-title>
<source>Protein Sci</source>
<volume>12</volume>
<fpage>2012</fpage>
<lpage>2112</lpage>
</element-citation>
      </ref>
      <ref id="pone.0032187-Kajander1">
        <label>17</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kajander</surname><given-names>T</given-names></name><name><surname>Lehtinen</surname><given-names>MJ</given-names></name><name><surname>Hyvarinen</surname><given-names>S</given-names></name><name><surname>Bhattacharjee</surname><given-names>A</given-names></name><name><surname>Leung</surname><given-names>E</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>108</volume>
<fpage>2897</fpage>
<lpage>2902</lpage>
<pub-id pub-id-type="pmid">21285368</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Morgan1">
        <label>18</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morgan</surname><given-names>HP</given-names></name><name><surname>Schmidt</surname><given-names>CQ</given-names></name><name><surname>Guariento</surname><given-names>M</given-names></name><name><surname>Blaum</surname><given-names>BS</given-names></name><name><surname>Gillespie</surname><given-names>D</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Structural basis for engagement by complement factor H of C3b on a self surface.</article-title>
<source>Nat Struct Mol Biol</source>
<volume>18</volume>
<fpage>463</fpage>
<lpage>470</lpage>
<pub-id pub-id-type="pmid">21317894</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Blackmore1">
        <label>19</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blackmore</surname><given-names>TK</given-names></name><name><surname>Hellwage</surname><given-names>J</given-names></name><name><surname>Sadlon</surname><given-names>TA</given-names></name><name><surname>Higgs</surname><given-names>N</given-names></name><name><surname>Zipfel</surname><given-names>PF</given-names></name><etal/></person-group>
<year>1998</year>
<article-title>Identification of the second heparin-binding domain in human complement factor H.</article-title>
<source>J Immunol</source>
<volume>160</volume>
<fpage>3342</fpage>
<lpage>3348</lpage>
<pub-id pub-id-type="pmid">9531293</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Blackmore2">
        <label>20</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Blackmore</surname><given-names>TK</given-names></name><name><surname>Sadlon</surname><given-names>TA</given-names></name><name><surname>Ward</surname><given-names>HM</given-names></name><name><surname>Lublin</surname><given-names>DM</given-names></name><name><surname>Gordon</surname><given-names>DL</given-names></name></person-group>
<year>1996</year>
<article-title>Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H.</article-title>
<source>J Immunol</source>
<volume>157</volume>
<fpage>5422</fpage>
<lpage>5427</lpage>
<pub-id pub-id-type="pmid">8955190</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Herbert1">
        <label>21</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Herbert</surname><given-names>AP</given-names></name><name><surname>Deakin</surname><given-names>JA</given-names></name><name><surname>Schmidt</surname><given-names>CQ</given-names></name><name><surname>Blaum</surname><given-names>BS</given-names></name><name><surname>Egan</surname><given-names>C</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism.</article-title>
<source>J Biol Chem</source>
<volume>282</volume>
<fpage>18960</fpage>
<lpage>18968</lpage>
<pub-id pub-id-type="pmid">17360715</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Morgan2">
        <label>22</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morgan</surname><given-names>HP</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Herbert</surname><given-names>AP</given-names></name><name><surname>Kavanagh</surname><given-names>D</given-names></name><name><surname>Uhrin</surname><given-names>D</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>Crystallographic determination of the disease-associated T1184R variant of complement regulator factor H.</article-title>
<source>Acta Crystallogr D Biol Crystallogr</source>
<volume>67</volume>
<fpage>593</fpage>
<lpage>600</lpage>
<pub-id pub-id-type="pmid">21697597</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Pangburn4">
        <label>23</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pangburn</surname><given-names>MK</given-names></name><name><surname>Atkinson</surname><given-names>MA</given-names></name><name><surname>Meri</surname><given-names>S</given-names></name></person-group>
<year>1991</year>
<article-title>Localization of the heparin-binding site on complement factor H.</article-title>
<source>J Biol Chem</source>
<volume>266</volume>
<fpage>16847</fpage>
<lpage>16853</lpage>
<pub-id pub-id-type="pmid">1832158</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Prosser1">
        <label>24</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prosser</surname><given-names>BE</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><name><surname>Roversi</surname><given-names>P</given-names></name><name><surname>Herbert</surname><given-names>AP</given-names></name><name><surname>Blaum</surname><given-names>BS</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Structural basis for complement factor H linked age-related macular degeneration.</article-title>
<source>J Exp Med</source>
<volume>204</volume>
<fpage>2277</fpage>
<lpage>2283</lpage>
<pub-id pub-id-type="pmid">17893204</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Aslam1">
        <label>25</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aslam</surname><given-names>M</given-names></name><name><surname>Perkins</surname><given-names>SJ</given-names></name></person-group>
<year>2001</year>
<article-title>Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling.</article-title>
<source>J Mol Biol</source>
<volume>309</volume>
<fpage>1117</fpage>
<lpage>1138</lpage>
<pub-id pub-id-type="pmid">11399083</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Fernando1">
        <label>26</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fernando</surname><given-names>AN</given-names></name><name><surname>Furtado</surname><given-names>PB</given-names></name><name><surname>Clark</surname><given-names>SJ</given-names></name><name><surname>Gilbert</surname><given-names>HE</given-names></name><name><surname>Day</surname><given-names>AJ</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Associative and structural properties of the region of complement factor H encompassing the Tyr402His disease-related polymorphism and its interactions with heparin.</article-title>
<source>J Mol Biol</source>
<volume>368</volume>
<fpage>564</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="pmid">17362990</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Okemefuna1">
        <label>27</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okemefuna</surname><given-names>AI</given-names></name><name><surname>Gilbert</surname><given-names>HE</given-names></name><name><surname>Griggs</surname><given-names>KM</given-names></name><name><surname>Ormsby</surname><given-names>RJ</given-names></name><name><surname>Gordon</surname><given-names>DL</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>The regulatory SCR-1/5 and cell surface-binding SCR-16/20 fragments of factor H reveal partially folded-back solution structures and different self-associative properties.</article-title>
<source>J Mol Biol</source>
<volume>375</volume>
<fpage>80</fpage>
<lpage>101</lpage>
<pub-id pub-id-type="pmid">18005991</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Oppermann1">
        <label>28</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oppermann</surname><given-names>M</given-names></name><name><surname>Manuelian</surname><given-names>T</given-names></name><name><surname>Jozsi</surname><given-names>M</given-names></name><name><surname>Brandt</surname><given-names>E</given-names></name><name><surname>Jokiranta</surname><given-names>TS</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein.</article-title>
<source>Clin Exp Immunol</source>
<volume>144</volume>
<fpage>342</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="pmid">16634809</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Schmidt3">
        <label>29</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>CQ</given-names></name><name><surname>Herbert</surname><given-names>AP</given-names></name><name><surname>Mertens</surname><given-names>HDT</given-names></name><name><surname>Guariento</surname><given-names>M</given-names></name><name><surname>Soares</surname><given-names>DC</given-names></name><etal/></person-group>
<year>2010</year>
<article-title>The Central Portion of Factor H (Modules 10â15) Is Compact and Contains a Structurally Deviant CCP Module.</article-title>
<source>J Mol Biol</source>
<volume>395</volume>
<fpage>105</fpage>
<lpage>122</lpage>
<pub-id pub-id-type="pmid">19835885</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-deCordoba1">
        <label>30</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>de Cordoba</surname><given-names>SR</given-names></name><name><surname>de Jorge</surname><given-names>EG</given-names></name></person-group>
<year>2008</year>
<article-title>Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H.</article-title>
<source>Clin Exp Immunol</source>
<volume>151</volume>
<fpage>1</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="pmid">18081690</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Boon1">
        <label>31</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boon</surname><given-names>CJ</given-names></name><name><surname>Klevering</surname><given-names>BJ</given-names></name><name><surname>Hoyng</surname><given-names>CB</given-names></name><name><surname>Zonneveld-Vrieling</surname><given-names>MN</given-names></name><name><surname>Nabuurs</surname><given-names>SB</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Basal laminar drusen caused by compound heterozygous variants in the CFH gene.</article-title>
<source>Am J Hum Genet</source>
<volume>82</volume>
<fpage>516</fpage>
<lpage>523</lpage>
<pub-id pub-id-type="pmid">18252232</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Perkins1">
        <label>32</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Perkins</surname><given-names>SJ</given-names></name><name><surname>Goodship</surname><given-names>TH</given-names></name></person-group>
<year>2002</year>
<article-title>Molecular modelling of the C-terminal domains of factor H of human complement: a correlation between haemolytic uraemic syndrome and a predicted heparin binding site.</article-title>
<source>J Mol Biol</source>
<volume>316</volume>
<fpage>217</fpage>
<lpage>224</lpage>
<pub-id pub-id-type="pmid">11851332</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Raychaudhuri1">
        <label>33</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Iartchouk</surname><given-names>O</given-names></name><name><surname>Chin</surname><given-names>K</given-names></name><name><surname>Tan</surname><given-names>PL</given-names></name><name><surname>Tai</surname><given-names>AK</given-names></name><etal/></person-group>
<year>2011</year>
<article-title>A rare penetrant mutation in CFH confers high risk of age-related macular degeneration.</article-title>
<source>Nat Genet</source>
<volume>43</volume>
<fpage>1232</fpage>
<lpage>1236</lpage>
<pub-id pub-id-type="pmid">22019782</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Richards1">
        <label>34</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richards</surname><given-names>A</given-names></name><name><surname>Buddles</surname><given-names>MR</given-names></name><name><surname>Donne</surname><given-names>RL</given-names></name><name><surname>Kaplan</surname><given-names>BS</given-names></name><name><surname>Kirk</surname><given-names>E</given-names></name><etal/></person-group>
<year>2001</year>
<article-title>Factor H mutations in hemolytic uremic syndrome cluster in exons 18â20, a domain important for host cell recognition.</article-title>
<source>Am J Hum Genet</source>
<volume>68</volume>
<fpage>485</fpage>
<lpage>490</lpage>
<pub-id pub-id-type="pmid">11170896</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Saunders1">
        <label>35</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saunders</surname><given-names>RE</given-names></name><name><surname>Goodship</surname><given-names>TH</given-names></name><name><surname>Zipfel</surname><given-names>PF</given-names></name><name><surname>Perkins</surname><given-names>SJ</given-names></name></person-group>
<year>2006</year>
<article-title>An interactive web database of factor H-associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease-associated mutations.</article-title>
<source>Hum Mutat</source>
<volume>27</volume>
<fpage>21</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">16281287</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Guigonis1">
        <label>36</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guigonis</surname><given-names>V</given-names></name><name><surname>Fremeaux-Bacchi</surname><given-names>V</given-names></name><name><surname>Giraudier</surname><given-names>S</given-names></name><name><surname>Favier</surname><given-names>R</given-names></name><name><surname>Borderie</surname><given-names>D</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Late-onset thrombocytic microangiopathy caused by cblC disease: association with a factor H mutation.</article-title>
<source>Am J Kidney Dis</source>
<volume>45</volume>
<fpage>588</fpage>
<lpage>595</lpage>
<pub-id pub-id-type="pmid">15754282</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Herbert2">
        <label>37</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Herbert</surname><given-names>AP</given-names></name><name><surname>Uhrin</surname><given-names>D</given-names></name><name><surname>Lyon</surname><given-names>M</given-names></name><name><surname>Pangburn</surname><given-names>MK</given-names></name><name><surname>Barlow</surname><given-names>PN</given-names></name></person-group>
<year>2006</year>
<article-title>Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure.</article-title>
<source>J Biol Chem</source>
<volume>281</volume>
<fpage>16512</fpage>
<lpage>16520</lpage>
<pub-id pub-id-type="pmid">16533809</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Potterton1">
        <label>38</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Potterton</surname><given-names>E</given-names></name><name><surname>Briggs</surname><given-names>P</given-names></name><name><surname>Turkenburg</surname><given-names>M</given-names></name><name><surname>Dodson</surname><given-names>E</given-names></name></person-group>
<year>2003</year>
<article-title>A graphical user interface to the CCP4 program suite.</article-title>
<source>Acta Crystallogr D Biol Crystallogr</source>
<volume>59</volume>
<fpage>1131</fpage>
<lpage>1137</lpage>
<pub-id pub-id-type="pmid">12832755</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Evans1">
        <label>39</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Evans</surname><given-names>P</given-names></name></person-group>
<year>2006</year>
<article-title>Scaling and assessment of data quality.</article-title>
<source>Acta Crystallogr D Biol Crystallogr</source>
<volume>62</volume>
<fpage>72</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="pmid">16369096</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-McCoy1">
        <label>40</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McCoy</surname><given-names>AJ</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Adams</surname><given-names>PD</given-names></name><name><surname>Winn</surname><given-names>MD</given-names></name><name><surname>Storoni</surname><given-names>LC</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>Phaser crystallographic software.</article-title>
<source>J Appl Crystallogr</source>
<volume>40</volume>
<fpage>658</fpage>
<lpage>674</lpage>
<pub-id pub-id-type="pmid">19461840</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Murshudov1">
        <label>41</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Murshudov</surname><given-names>GN</given-names></name><name><surname>Vagin</surname><given-names>AA</given-names></name><name><surname>Dodson</surname><given-names>EJ</given-names></name></person-group>
<year>1997</year>
<article-title>Refinement of macromolecular structures by the maximum-likelihood method.</article-title>
<source>Acta Crystallogr D Biol Crystallogr</source>
<volume>53</volume>
<fpage>240</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="pmid">15299926</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Terwilliger1">
        <label>42</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Terwilliger</surname><given-names>TC</given-names></name><name><surname>Grosse-Kunstleve</surname><given-names>RW</given-names></name><name><surname>Afonine</surname><given-names>PV</given-names></name><name><surname>Moriarty</surname><given-names>NW</given-names></name><name><surname>Zwart</surname><given-names>PH</given-names></name><etal/></person-group>
<year>2008</year>
<article-title>Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard.</article-title>
<source>Acta Crystallogr D Biol Crystallogr</source>
<volume>64</volume>
<fpage>61</fpage>
<lpage>69</lpage>
<pub-id pub-id-type="pmid">18094468</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Emsley1">
        <label>43</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Emsley</surname><given-names>P</given-names></name><name><surname>Cowtan</surname><given-names>K</given-names></name></person-group>
<year>2004</year>
<article-title>Coot: model-building tools for molecular graphics.</article-title>
<source>Acta Crystallogr D-Biol Crystallogr</source>
<volume>60</volume>
<fpage>2126</fpage>
<lpage>2132</lpage>
<pub-id pub-id-type="pmid">15572765</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Davis1">
        <label>44</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Davis</surname><given-names>IW</given-names></name><name><surname>Leaver-Fay</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>VB</given-names></name><name><surname>Block</surname><given-names>JN</given-names></name><name><surname>Kapral</surname><given-names>GJ</given-names></name><etal/></person-group>
<year>2007</year>
<article-title>MolProbity: all-atom contacts and structure validation for proteins and nucleic acids.</article-title>
<source>Nucleic Acids Res</source>
<volume>35</volume>
<fpage>W375</fpage>
<lpage>W383</lpage>
<pub-id pub-id-type="pmid">17452350</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Maleknia1">
        <label>45</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maleknia</surname><given-names>SD</given-names></name><name><surname>Ralston</surname><given-names>CY</given-names></name><name><surname>Brenowitz</surname><given-names>MD</given-names></name><name><surname>Downard</surname><given-names>KM</given-names></name><name><surname>Chance</surname><given-names>MR</given-names></name></person-group>
<year>2001</year>
<article-title>Determination of macromolecular folding and structure by synchrotron x-ray radiolysis techniques.</article-title>
<source>Anal Biochem</source>
<volume>289</volume>
<fpage>103</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="pmid">11161303</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Konarev1">
        <label>46</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Konarev</surname><given-names>PV</given-names></name><name><surname>Volkov</surname><given-names>VV</given-names></name><name><surname>Sokolova</surname><given-names>AV</given-names></name><name><surname>Koch</surname><given-names>MHJ</given-names></name><name><surname>Svergun</surname><given-names>DI</given-names></name></person-group>
<year>2003</year>
<article-title>PRIMUS: a Windows PC-based system for small-angle scattering data analysis.</article-title>
<source>J Appl Crystallogr</source>
<volume>36</volume>
<fpage>1277</fpage>
<lpage>1282</lpage>
</element-citation>
      </ref>
      <ref id="pone.0032187-Svergun1">
        <label>47</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Svergun</surname><given-names>D</given-names></name><name><surname>Barberato</surname><given-names>C</given-names></name><name><surname>Koch</surname><given-names>MHJ</given-names></name></person-group>
<year>1995</year>
<article-title>CRYSOL - a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic Coordinates.</article-title>
<source>J Appl Crystallogr</source>
<volume>28</volume>
<fpage>768</fpage>
<lpage>773</lpage>
</element-citation>
      </ref>
      <ref id="pone.0032187-Franke1">
        <label>48</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Franke</surname><given-names>D</given-names></name><name><surname>Svergun</surname><given-names>DI</given-names></name></person-group>
<year>2009</year>
<article-title>DAMMIF, a program for rapid ab-initio shape determination in small-angle scattering.</article-title>
<source>J Appl Crystallogr</source>
<volume>42</volume>
<fpage>342</fpage>
<lpage>346</lpage>
<pub-id pub-id-type="pmid">27630371</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Volkov1">
        <label>49</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Volkov</surname><given-names>VV</given-names></name><name><surname>Svergun</surname><given-names>DI</given-names></name></person-group>
<year>2003</year>
<article-title>Uniqueness of ab initio shape determination in small-angle scattering.</article-title>
<source>J Appl Crystallogr</source>
<volume>36</volume>
<fpage>860</fpage>
<lpage>864</lpage>
</element-citation>
      </ref>
      <ref id="pone.0032187-Kozin1">
        <label>50</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kozin</surname><given-names>MB</given-names></name><name><surname>Svergun</surname><given-names>DI</given-names></name></person-group>
<year>2001</year>
<article-title>Automated matching of high- and low-resolution structural models.</article-title>
<source>J Appl Crystallogr</source>
<volume>34</volume>
<fpage>33</fpage>
<lpage>41</lpage>
</element-citation>
      </ref>
      <ref id="pone.0032187-Petoukhov1">
        <label>51</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Petoukhov</surname><given-names>MV</given-names></name><name><surname>Svergun</surname><given-names>DI</given-names></name></person-group>
<year>2005</year>
<article-title>Global rigid body modeling of macromolecular complexes against small-angle scattering data.</article-title>
<source>Biophys J</source>
<volume>89</volume>
<fpage>1237</fpage>
<lpage>1250</lpage>
<pub-id pub-id-type="pmid">15923225</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Bernado1">
        <label>52</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bernado</surname><given-names>P</given-names></name><name><surname>Mylonas</surname><given-names>E</given-names></name><name><surname>Petoukhov</surname><given-names>MV</given-names></name><name><surname>Blackledge</surname><given-names>M</given-names></name><name><surname>Svergun</surname><given-names>DI</given-names></name></person-group>
<year>2007</year>
<article-title>Structural characterization of flexible proteins using small-angle X-ray scattering.</article-title>
<source>J Am Chem Soc</source>
<volume>129</volume>
<fpage>5656</fpage>
<lpage>5664</lpage>
<pub-id pub-id-type="pmid">17411046</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Bhattacharjee1">
        <label>53</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bhattacharjee</surname><given-names>A</given-names></name><name><surname>Lehtinen</surname><given-names>MJ</given-names></name><name><surname>Kajander</surname><given-names>T</given-names></name><name><surname>Goldman</surname><given-names>A</given-names></name><name><surname>Jokiranta</surname><given-names>TS</given-names></name></person-group>
<year>2010</year>
<article-title>Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d.</article-title>
<source>Mol Immunol</source>
<volume>47</volume>
<fpage>1686</fpage>
<lpage>1691</lpage>
<pub-id pub-id-type="pmid">20378178</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Jokiranta1">
        <label>54</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jokiranta</surname><given-names>TS</given-names></name><name><surname>Jaakola</surname><given-names>VP</given-names></name><name><surname>Lehtinen</surname><given-names>MJ</given-names></name><name><surname>Parepalo</surname><given-names>M</given-names></name><name><surname>Meri</surname><given-names>S</given-names></name><etal/></person-group>
<year>2006</year>
<article-title>Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.</article-title>
<source>Embo J</source>
<volume>25</volume>
<fpage>1784</fpage>
<lpage>1794</lpage>
<pub-id pub-id-type="pmid">16601698</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Soares1">
        <label>55</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Soares</surname><given-names>DC</given-names></name><name><surname>Gerloff</surname><given-names>DL</given-names></name><name><surname>Syme</surname><given-names>NR</given-names></name><name><surname>Coulson</surname><given-names>AF</given-names></name><name><surname>Parkinson</surname><given-names>J</given-names></name><etal/></person-group>
<year>2005</year>
<article-title>Large-scale modelling as a route to multiple surface comparisons of the CCP module family.</article-title>
<source>Protein Eng Des Sel</source>
<volume>18</volume>
<fpage>379</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="pmid">15976010</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Kirkitadze2">
        <label>56</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirkitadze</surname><given-names>MD</given-names></name><name><surname>Henderson</surname><given-names>C</given-names></name><name><surname>Price</surname><given-names>NC</given-names></name><name><surname>Kelly</surname><given-names>SM</given-names></name><name><surname>Mullin</surname><given-names>NP</given-names></name><etal/></person-group>
<year>1999</year>
<article-title>Central modules of the vaccinia virus complement control protein are not in extensive contact.</article-title>
<source>Biochem J</source>
<volume>344 Pt 1</volume>
<fpage>167</fpage>
<lpage>175</lpage>
<pub-id pub-id-type="pmid">10548547</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Kirkitadze3">
        <label>57</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kirkitadze</surname><given-names>MD</given-names></name><name><surname>Krych</surname><given-names>M</given-names></name><name><surname>Uhrin</surname><given-names>D</given-names></name><name><surname>Dryden</surname><given-names>DT</given-names></name><name><surname>Smith</surname><given-names>BO</given-names></name><etal/></person-group>
<year>1999</year>
<article-title>Independently melting modules and highly structured intermodular junctions within complement receptor type 1.</article-title>
<source>Biochemistry</source>
<volume>38</volume>
<fpage>7019</fpage>
<lpage>7031</lpage>
<pub-id pub-id-type="pmid">10353813</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Soares2">
        <label>58</label>
        <element-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Soares</surname><given-names>DC</given-names></name><name><surname>Barlow</surname><given-names>PN</given-names></name></person-group>
<year>2005</year>
<article-title>Complement control protein modules in the regulators of complement activation.</article-title>
<person-group person-group-type="editor"><name><surname>Morikis</surname><given-names>D</given-names></name><name><surname>Lambris</surname><given-names>JD</given-names></name></person-group>
<source>Structural Biology of the Complement System</source>
<publisher-loc>Boca Raton</publisher-loc>
<publisher-name>CRC Press, Taylor &amp; Francis Group</publisher-name>
<fpage>19</fpage>
<lpage>62</lpage>
</element-citation>
      </ref>
      <ref id="pone.0032187-Ferreira1">
        <label>59</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferreira</surname><given-names>VP</given-names></name><name><surname>Herbert</surname><given-names>AP</given-names></name><name><surname>Cortes</surname><given-names>C</given-names></name><name><surname>McKee</surname><given-names>KA</given-names></name><name><surname>Blaum</surname><given-names>BS</given-names></name><etal/></person-group>
<year>2009</year>
<article-title>The Binding of Factor H to a Complex of Physiological Polyanions and C3b on Cells Is Impaired in Atypical Hemolytic Uremic Syndrome.</article-title>
<source>J Immunol</source>
<volume>182</volume>
<fpage>7009</fpage>
<lpage>7018</lpage>
<pub-id pub-id-type="pmid">19454698</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Lehtinen1">
        <label>60</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lehtinen</surname><given-names>MJ</given-names></name><name><surname>Rops</surname><given-names>AL</given-names></name><name><surname>Isenman</surname><given-names>DE</given-names></name><name><surname>van der Vlag</surname><given-names>J</given-names></name><name><surname>Jokiranta</surname><given-names>TS</given-names></name></person-group>
<year>2009</year>
<article-title>Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.</article-title>
<source>J Biol Chem</source>
<volume>284</volume>
<fpage>15650</fpage>
<lpage>15658</lpage>
<pub-id pub-id-type="pmid">19351878</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Okemefuna2">
        <label>61</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Okemefuna</surname><given-names>AI</given-names></name><name><surname>Nan</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>A</given-names></name><name><surname>Gor</surname><given-names>J</given-names></name><name><surname>Perkins</surname><given-names>SJ</given-names></name></person-group>
<year>2010</year>
<article-title>Complement factor H binds at two independent sites to C-reactive protein in acute phase concentrations.</article-title>
<source>J Biol Chem</source>
<volume>285</volume>
<fpage>1053</fpage>
<lpage>1065</lpage>
<pub-id pub-id-type="pmid">19850925</pub-id></element-citation>
      </ref>
      <ref id="pone.0032187-Guinier1">
        <label>62</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guinier</surname><given-names>A</given-names></name></person-group>
<year>1939</year>
<article-title>La diffraction des rayons X aux tres petits angles; application a l'etude de phenomenes ultramicroscopiques.</article-title>
<source>Ann Phys (Paris)</source>
<volume>12</volume>
<fpage>161</fpage>
<lpage>237</lpage>
</element-citation>
      </ref>
      <ref id="pone.0032187-Svergun2">
        <label>63</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Svergun</surname><given-names>DI</given-names></name></person-group>
<year>1992</year>
<article-title>Determination of the regularization parameter in indirect-transform methods using perceptual criteria.</article-title>
<source>J Appl Crystallogr</source>
<volume>25</volume>
<fpage>495</fpage>
<lpage>503</lpage>
</element-citation>
      </ref>
      <ref id="pone.0032187-Baker1">
        <label>64</label>
        <element-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baker</surname><given-names>NA</given-names></name><name><surname>Sept</surname><given-names>D</given-names></name><name><surname>Joseph</surname><given-names>S</given-names></name><name><surname>Holst</surname><given-names>MJ</given-names></name><name><surname>McCammon</surname><given-names>JA</given-names></name></person-group>
<year>2001</year>
<article-title>Electrostatics of nanosystems: application to microtubules and the ribosome.</article-title>
<source>Proc Natl Acad Sci U S A</source>
<volume>98</volume>
<fpage>10037</fpage>
<lpage>10041</lpage>
<pub-id pub-id-type="pmid">11517324</pub-id></element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>